Target intelligence / Profile preview

Cytochrome c oxidase complex (COX or Complex IV)

Target
COX or Complex IV
Molecular classification
Enzyme, Oxidoreductase (EC 7.1.1.9; formerly EC 1.9.3.1), Multisubunit protein complex, Terminal enzyme of the mitochondrial electron transport chain
01

Overview

Cytochrome c oxidase complex is a large multisubunit transmembrane enzyme found in mitochondria (and some prokaryotes), also known as **Complex IV** of the respiratory electron transport chain.[4][6] It catalyzes the final step of aerobic respiration by transferring electrons from reduced cytochrome c to molecular oxygen, reducing it to water while simultaneously pumping protons across the inner mitochondrial membrane—this process generates an electrochemical gradient essential for ATP synthesis via oxidative phosphorylation.[2][8] The human enzyme consists of 14 subunits with three core catalytic subunits encoded by mitochondrial DNA (MT‑CO1/COX I, MT‑CO2/COX II, MT‑CO3/COX III) and additional structural/regulatory subunits encoded by nuclear DNA.[4][6] Dysfunction or inhibition results in severe impairment of energy metabolism with broad clinical consequences ranging from acute toxicity (as seen with cyanide) to chronic degenerative disease states linked with inherited mutations or acquired defects.[1][8]

Other names
Complex IVCOXCytochrome c oxidaseMitochondrial complex IVElectron transport chain complex IV
02

Mechanism of action

Drugs targeting this molecule typically act as **enzyme inhibitors** by binding to the active site or regulatory sites, blocking electron transfer and halting cellular respiration, which can lead to chemical asphyxiation at the cellular level.[3]

03

Biological functions

Cellular respiration (aerobic metabolism)Oxidative phosphorylationElectron transfer from cytochrome c to molecular oxygenProton pumping across the mitochondrial inner membrane
04

Disease associations

Mitochondrial diseases (e.g., Complex IV deficiency, Leber's hereditary optic neuropathy)CancerSensorineural deafnessRecurrent myoglobinuria
05

Safety considerations

Inhibition leads rapidly to cell death due to loss of ATP production; thus, drugs that inhibit cytochrome c oxidase are highly toxic (e.g., cyanide poisoning). Off-target inhibition is a major safety concern.
06

Interacting drugs

Cyanide

2 more in the full profile.

07

Biomarkers

Mutations in subunits such as MT‑CO1 are used as biomarkers for certain mitochondrial diseases including Leber's hereditary optic neuropathy and some forms of anemia.[1]

Beyond the preview

Go deeper on Cytochrome c oxidase complex (COX or Complex IV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c oxidase complex (COX or Complex IV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call